Found: 18
Select item for more details and to access through your institution.
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
- Published in:
- European Radiology, 2023, v. 33, n. 1, p. 512, doi. 10.1007/s00330-022-08980-4
- By:
- Publication type:
- Article
Solving the deficit of cancer pain management skills by education programs.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 4, p. 1843, doi. 10.1007/s00520-020-05651-2
- By:
- Publication type:
- Article
MicroRNA-338 Inhibits Growth, Invasion and Metastasis of Gastric Cancer by Targeting NRP1 Expression.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0094422
- By:
- Publication type:
- Article
Polatuzumab vedotin–based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 2, p. 349, doi. 10.1007/s00277-021-04711-9
- By:
- Publication type:
- Article
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma.
- Published in:
- Journal of Hepatocellular Carcinoma, 2024, v. 11, p. 1015, doi. 10.2147/JHC.S462470
- By:
- Publication type:
- Article
Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5142, doi. 10.3390/cancers13205142
- By:
- Publication type:
- Article
Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 11, p. 2184, doi. 10.1111/liv.14210
- By:
- Publication type:
- Article
Detection of human papillomavirus in esophageal carcinoma.
- Published in:
- Journal of Medical Virology, 2002, v. 68, n. 3, p. 412, doi. 10.1002/jmv.10219
- By:
- Publication type:
- Article
Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma– with Emphasis on Locoregional Therapy for Oligoprogression.
- Published in:
- Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 509, doi. 10.1159/000536549
- By:
- Publication type:
- Article
Targeting tumor‐infiltrating Ly6G<sup>+</sup> myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 9, p. 1878, doi. 10.1002/ijc.31216
- By:
- Publication type:
- Article
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 6, p. 1210, doi. 10.1002/cncr.27800
- By:
- Publication type:
- Article
Normal and Perturbed Endothelial Cells from Canine Femoral Arteries and Femoral Veins Exhibit Heterogeneity in Hemostatic Properties and Growth Characteristics.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2002, v. 14, n. 1, p. 25, doi. 10.1023/A:1022010220420
- By:
- Publication type:
- Article
ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis.
- Published in:
- Oncology, 2022, v. 100, n. 8, p. 419, doi. 10.1159/000525239
- By:
- Publication type:
- Article
Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 652, doi. 10.1159/000517738
- By:
- Publication type:
- Article
Treatment Efficacy Differences of Sorafenib for Advanced Hepatocellular Carcinoma: A Meta-Analysis of Randomized Clinical Trials.
- Published in:
- Oncology, 2015, v. 88, n. 6, p. 345, doi. 10.1159/000369559
- By:
- Publication type:
- Article
β-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
β-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2014, v. 87, n. 3, p. 159, doi. 10.1159/000362821
- By:
- Publication type:
- Article
Atezolizumab plus bevacizumab combination enables an unresectable hepatocellular carcinoma resectable and links immune exclusion and tumor dedifferentiation to acquired resistance.
- Published in:
- 2021
- By:
- Publication type:
- Letter